Schonfeld Strategic Advisors LLC Medicinova Inc Transaction History
Schonfeld Strategic Advisors LLC
- $12.5 Billion
- Q2 2025
A detailed history of Schonfeld Strategic Advisors LLC transactions in Medicinova Inc stock. As of the latest transaction made, Schonfeld Strategic Advisors LLC holds 34,750 shares of MNOV stock, worth $45,175. This represents 0.0% of its overall portfolio holdings.
Number of Shares
34,750
Previous 35,138
1.1%
Holding current value
$45,175
Previous $51,000
11.76%
% of portfolio
0.0%
Previous 0.0%
Shares
15 transactions
Others Institutions Holding MNOV
# of Institutions
22Shares Held
5.08MCall Options Held
0Put Options Held
0-
Essex Woodlands Management, Inc. The Woodlands, TX1.11MShares$1.44 Million0.52% of portfolio
-
Black Rock Inc. New York, NY695KShares$903,4250.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA687KShares$892,5500.0% of portfolio
-
Citigroup Inc592KShares$769,5440.0% of portfolio
-
Geode Capital Management, LLC Boston, MA526KShares$683,6590.0% of portfolio
About MEDICINOVA INC
- Ticker MNOV
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 49,046,200
- Market Cap $63.8M
- Description
- MediciNova, Inc., a biopharmaceutical company, focuses on developing novel and small molecule therapeutics for the treatment of serious diseases with unmet medical needs in the United States. The company is developing MN-166 (ibudilast), an oral anti-inflammatory and neuroprotective agent for treating neurological disorders, such as primary and ...